Human IL-2 Receptor alpha ELISA Kit

Key features and details

  • Specification: 96 Test
  • Sensitivity: 0.01 pg/ml (50 μl);1.14 pg/ml (10 μl);
  • Standard Curve Range: 1.37~1000 pg/ml
  • Standard Curve Gradient: 7 Points/3 Folds
  • Number of Incubations: 2
  • Sample Volume: 50 μl/10 μl
  • Assay type: Sandwich Elisa
  • Operation Duration: 120min
  • Brand:
CAT.NO. : AEH0170
US$ Please choose
US$ Please choose
Size:
96T
Trail, Bulk size or Custom requests Please contact us
Product Details
Background
Two type1 membrane proteins belonging to the hemopoietin receptor family have been cloned and shown to bind IL-13 with differing affinities. The lower affinity IL-13 binding protein, previously designated IL-13 R alpha, IL-13 R alpha l or NR4, is now referred to as IL-13 R alpha 1. The high affinity IL-13 binding protein, previously also designated IL-13 R or IL-13 R alpha l, is now referred to as IL-13 R alpha 2. Human IL-13 R alpha 2 was originally cloned from the Caki-1 human renal carcinoma cell line. The IL-13 R alpha 2 cDNA encodes a 380 amino acid (aa) residue precursor protein with a putative 26 aa residue signal peptide, a 317 residue extracellular domain, a 20 aa residue transmembrane region and a 17 aa residue cytoplasmic tail. Human and mouse IL‑13 R alpha 2 share 59% aa sequence identity. The extracellular domain of IL-13 R alpha 2 is also closely related to that of IL-13 R alpha 1. However, the 17 aa residue cytoplasmic domain of IL-13 R alpha 2 is much shorter than that of IL-13 R alpha 1, suggesting that the two receptors are functionally distinct. IL-13 R alpha 1 has been shown to combine with the IL-4 R to form a high-affinity receptor complex capable of transducing an IL‑13‑dependent proliferative signal. The role of IL-13 R alpha 2 in IL-13 signaling remains to be elucidated. The amino-terminal 27 aa residues of the human and mouse IL‑13 R alpha 2 are nearly identical to that of a soluble mouse IL-13 binding protein purified from mouse serum and urine.
Typical data

pg/ml

O.D.

Average

Corrected

0.00

0.0082

0.0086

0.0084

1.37

0.0274

0.0256

0.0265

0.0181

4.12

0.0649

0.0683

0.0666

0.0582

12.35

0.1922

0.1804

0.1863

0.1779

37.04

0.4898

0.4806

0.4852

0.4768

111.11

1.2600

1.1500

1.2050

1.1966

333.33

2.4250

2.4020

2.4135

2.4051

1000.00

3.6340

3.6390

3.6365

3.6281

Precision

Intra-assay Precision

Inter-assay Precision

Sample Number

S1

S2

S3

S1

S2

S3

22

22

22

6

6

6

Average(pg/ml)

19.2

115.7

350.8

18.1

103.6

361.9

Standard Deviation

0.9

5.4

18.3

0.7

4.9

14.8

Coefficient of Variation(%)

4.7

4.7

5.2

3.9

4.7

4.1

Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.
Spike Recovery
The spike recovery was evaluated by spiking 3 levels of human IL-2 Receptor alpha into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 89% to 118% with an overall mean recovery of 106%.
Sample Values
Sample Matrix Sample Evaluated Range (pg/ml) Detectable (%) Mean of Detectable (pg/ml)
Serum 30 722.90-1772.29 100 1340.94
Serum/Plasma – Thirty samples from apparently healthy volunteers were evaluated for the presence of IL-2 Receptor alpha in this assay. No medical histories were available for the donors.
New Products
Get in touch with AREX
Name:*
Tel/Phone:*
Company:*
Email:*
Inquiry:
Captcha*
Submitting your email information means that you are willing to receive email information from AREX regarding technology, applications, products, and events. By clicking on the 'unsubscribe' button in the email or by contacting info@arexbio.com You can unsubscribe at any time by sending an email. Regarding your data usage information, please refer to our privacy policy.
© AREX 2024. All Rights Reserved. Sitemap
0.844772s